Nesbit Lecture: "BRAF to The Future: Novel Targeted Therapies for LCH and Other Histiocytic Disorders" with Ashish Kumar, MD, PhD (6.25.25)

Nesbit Lecture: "BRAF to The Future: Novel Targeted Therapies for LCH and Other Histiocytic Disorders"

6/25/25

Ashish Kumar, MD, PhD
Pediatric hematologist/oncologist, Cincinnati Children's Hospital

Objectives: 

1. Understand the pathophysiology and clinical features of histiocytic disorders
2. Recognize the limitations of current treatments
3. Identify novel therapeutic approaches